Genfit SA (GNFT):企業の財務・戦略的SWOT分析

◆英語タイトル:Genfit SA (GNFT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15091
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, biomarkers, TGFTX1 and TGFTX4. Its TGFTX1 is a research program for auto-immune and inflammatory diseases; and TGFTX4 for fibrotic diseases. Genfit develops diagnostic solutions in various therapeutic areas such as metabolic diseases, liver diseases, non-alcoholic steatohepatitis, cholestatic liver diseases, inflammation and autoimmune diseases, and inflammatory bowel diseases. The company’s research and development activities include multiple drug candidate research programs targeting novel mechanisms of action such as the inhibition of ROR?-t. It has presence in France and the US. Genfit is headquartered in Loos, France.

Genfit SA Key Recent Developments

Feb 04,2019: GENFIT: Reports full-year 2018 financial results: cash position of €207.2m as of 12.31.2018
Jan 04,2019: Genfit, Covance sign licensing agreement for NASH diagnostic test
Oct 23,2018: Genfit: Third quarter 2018 financial information
Oct 02,2018: GENFIT New data to be presented at 2018 AASLD meeting ahead of key results expected in 2018 and 2019
Sep 26,2018: GENFIT: further details on management changes

This comprehensive SWOT profile of Genfit SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Genfit SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Genfit SA – Key Information
Genfit SA – Overview
Genfit SA – Key Employees
Genfit SA – Key Employee Biographies
Genfit SA – Key Operational Heads
Genfit SA – Major Products and Services
Genfit SA – History
Genfit SA – Company Statement
Genfit SA – Locations And Subsidiaries
Genfit SA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Genfit SA – Business Description
Genfit SA – Corporate Strategy
Genfit SA – SWOT Analysis
SWOT Analysis – Overview
Genfit SA – Strengths
Genfit SA – Weaknesses
Genfit SA – Opportunities
Genfit SA – Threats
Genfit SA – Key Competitors

Section 3 – Company Financial Performance Charts

Genfit SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Genfit SA, Key Information
Genfit SA, Key Ratios
Genfit SA, Share Data
Genfit SA, Major Products and Services
Genfit SA, History
Genfit SA, Key Employees
Genfit SA, Key Employee Biographies
Genfit SA, Key Operational Heads
Genfit SA, Other Locations
Genfit SA, Subsidiaries
Genfit SA, Key Manufacturing facilities
Genfit SA, Key Competitors
Genfit SA, SWOT Analysis
Genfit SA, Ratios based on current share price
Genfit SA, Annual Ratios
Genfit SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Genfit SA, Performance Chart
Genfit SA, Ratio Charts

★海外企業調査レポート[Genfit SA (GNFT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pacira Pharmaceuticals Inc (PCRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Pacira Pharmaceuticals Inc (Pacira) discovers, develops, manufactures and commercializes drugs based on its proprietary DepoFoam drug delivery technology. Its lead product candidate, Exparel (bupivacaine liposome injectable suspension) is an amide-type local anesthetic indicated for infiltra …
  • McDonald’s Australia Limited:企業の戦略的SWOT分析
    McDonald's Australia Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Genentech Inc:医療機器:M&Aディール及び事業提携情報
    Summary Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including bio-oncology, immunology, ophthalmology …
  • CareCloud Corp:医療機器:M&Aディール及び事業提携情報
    Summary CareCloud Corp (CareCloud) is a healthcare technology company that offers cloud healthcare solutions. The company offers cloud-based healthcare IT solutions. It offers revenue cycle management, electronic health records, patient engagement, practice management, and others. CareCloud provides …
  • Tanfield Group PLC (TAN):企業の財務・戦略的SWOT分析
    Summary Tanfield Group plc (Tanfield Group) is an investment company that offers electrical investments. The company designs and produces electric commercial vehicles for short haul urban fleets. It also produces zero-emission vehicles that deliver better performance to traditional diesel trucks. Ta …
  • Hyundai Corporation:企業の戦略・SWOT・財務情報
    Hyundai Corporation - Strategy, SWOT and Corporate Finance Report Summary Hyundai Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Minoryx Therapeutics sl:製薬・医療:M&Aディール及び事業提携情報
    Summary Minoryx Therapeutics sl (Minoryx) is a clinical stage biotechnology company that develops treatments for life threatening rare diseases. The company offers discovery, preclinical research, development and clinical trial programs. It develops ALD-MIN, morquio B and PCT drugs used for lysosoma …
  • Titan Logix Corp (TLA):企業の財務・戦略的SWOT分析
    Summary Titan Logix Corp (Titan) is a technology company that offers research and development, manufacturing and marketing of advanced technology fluid management solutions. The company's products include stationary guided wave radar gauges for level measurement and overfill prevention, for use in t …
  • PNC Wealth Management:企業の戦略・SWOT・財務情報
    PNC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary PNC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • CAT Telecom Public Co Ltd:企業の戦略的SWOT分析
    CAT Telecom Public Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Myriad Genetics, Inc.:企業の戦略・SWOT・財務分析
    Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report Summary Myriad Genetics, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Walmart de Mexico y Centroamerica:企業の戦略・SWOT・財務情報
    Walmart de Mexico y Centroamerica - Strategy, SWOT and Corporate Finance Report Summary Walmart de Mexico y Centroamerica - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • S&C Electric Co:企業の戦略的SWOT分析
    S&C Electric Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Rajesh Exports Limited
    Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report Summary Rajesh Exports Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Neuwave Medical Inc-医療機器分野:企業M&A・提携分析
    Summary NeuWave Medical Inc (NeuWave), a subsidiary of Ethicon US LLC is a medical device company that develops and commercializes energy-based minimally invasive medical devices. Its flagship product, Certus 140 microwave ablation (coagulation) system, is a minimally invasive soft tissue ablation s …
  • Xped Limited (XPE)-石油・ガス分野:企業M&A・提携分析
    Summary Xped Limited (Xped) formerly Raya Group Limited, is an Internet of Things company that develops software and hardware solutions. It offers auto discovery remote control, Xerts, and Xped app software; and hardware such as Xped ADRC Shields, Umbo-Xped ADRC Hub, UltraPlug, VariPlug, IRBlaster. …
  • Poyry PLC:企業のM&A・事業提携・投資動向
    Poyry PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Poyry PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Sembcorp Industries Ltd (U96)-石油・ガス分野:企業M&A・提携分析
    Summary Sembcorp Industries Limited (Sembcorp) is a diversified energy, water and marine company. The company’s utilities division provides energy and water to industrial and municipal customers. Its energy operations include power generation, steam production and supply and natural gas import suppl …
  • Abreos Biosciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Abreos Biosciences Inc (Abreos Biosciences) is a biotechnology company that develops laboratory-based and point-of-care (POC) tests for precision dosing of biologic drugs. The company’s technology platform veritope, allow monitoring of monoclonal antibody drug levels in blood (novel or biosi …
  • AMERCO:企業の戦略・SWOT・財務情報
    AMERCO - Strategy, SWOT and Corporate Finance Report Summary AMERCO - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆